Inventaire - your friends and communities are your best library - Inventaire

Probiotics: from bench to market

author

Tri Duong

published in: Annals of the New York Academy of Sciences

date of publication: 2010-11-01

language: English

main subject: probiotics

Cites articles 56

Date

Title

Authors

2010-04-30

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

Mary C. Rea, John Christopher Vederas, Reynolds Paul Ross, Colin Hill
2010-06-25

Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations

Justin L Sonnenburg, Erica D. Sonnenburg, Steven Higginbottom
2010-06-29

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon

Mary C. Rea, Fiona Fouhy, Paul D. Cotter, Fergus Shanahan, Colin Hill, Reynolds Paul Ross
2010-07-23

Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling

Philip M. Sherman
2009-02-11

Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study
2009-01-01

Alterations in the intestinal microbiota and functional bowel symptoms
2009-02-25

Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge

Tri Duong, Todd R. Klaenhammer
2009-05-01

Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy

Todd R. Klaenhammer
2009-06-29

Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model

Thierno Madjou Bah
2009-04-01

Lactobacillus strains stabilize intestinal microbiota in Japanese cedar pollinosis patients
2009-11-01

Tumor necrosis factor-alpha participates in apoptosis in the limbic system after myocardial infarction.

Philippe Ryvlin
2009-09-16

A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea
2009-10-05

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Jean-Charles Fruchart, American Heart Association, Paul Zimmet, Sidney C Smith
2009-11

Intestinal mucosal barrier function in health and disease
2009-11-29

Probiotics and pharmabiotics: alternative medicine or an evidence-based alternative?

Colin Hill
2008-03-01

Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria

Todd R. Klaenhammer
2008-03-01

Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study
2008-05-01

Meta-analysis of probiotics for the treatment of irritable bowel syndrome
2008-07-01

Recommendations for probiotic use--2008.

Erika Isolauri, Christina M. Surawicz, Patricia L Hibberd
2008-08-01

Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation

John MacSharry, Fergus Shanahan
2008-08-23

Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses

Siobhain M O' Mahony, John F. Cryan, Timothy G. Dinan, Julian R Marchesi, Eamonn M M Quigley
2008-08-22

Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression

Arthur C Ouwehand
2008-09-17

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

Peter J Whorwell
2008-10-01

Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions

Philip M. Sherman
2008-11-01

Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers

Parveen Yaqoob
2008-12-02

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
2008-12-17

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

Paul Moayyedi, Alexander C. Ford, Nicholas Talley
2008-09-01

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis

Julian Panes
2007-01

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study
2007-03-05

Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation

Philip M. Sherman, Glenda MacQueen
2007-03-15

Adrenergic regulation of bacterial virulence

Vanessa Sperandio, Matthew Waldor
2007-04-24

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

Sinéad C Corr, Christian U Riedel, Yin Li, Paul W O'Toole, Colin Hill

Article - wd:Q82596467

Welcome to Inventaire

the library of your friends and communities

you are offline